Lexaria Bioscience Corp. (LEXX) stock
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
$4.18−0.23 (-5.22%)
Close on Nov 17, 2026Market cap $103.61MP/E –Yield –
Lexaria Bioscience cash
Cash and short-term investments held at the end of each period.
Lexaria Bioscience's cash was $3.64M at May 31, 2026. For fiscal 2025 it was $1.95M, down 70.3% from the year before. Over ten years it grew 22.3% a year on average. The highest annual figure on record is $11.75M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Aug 31, 2025 | $1.95M | -70.3% |
| FY2024 | Aug 31, 2024 | $6.56M | +343.6% |
| FY2023 | Aug 31, 2023 | $1.48M | -76.0% |
| FY2022 | Aug 31, 2022 | $6.16M | -47.6% |
| FY2021 | Aug 31, 2021 | $11.75M | +795.0% |
| FY2020 | Aug 31, 2020 | $1.31M | -2.7% |
| FY2019 | Aug 31, 2019 | $1.35M | -22.3% |
| FY2018 | Aug 31, 2018 | $1.74M | -31.4% |
| FY2017 | Aug 31, 2017 | $2.53M | +2612.1% |
| FY2016 | Aug 31, 2016 | $93.41K | -64.1% |
| FY2015 | Aug 31, 2015 | $260.08K | +296.8% |
| FY2013 | Oct 31, 2013 | $65.54K | -63.7% |
| FY2012 | Oct 31, 2012 | $180.51K | +478.6% |
| FY2011 | Oct 31, 2011 | $31.20K | -50.5% |
| FY2010 | Oct 31, 2010 | $62.99K | -80.9% |
| FY2009 | Oct 31, 2009 | $330.17K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | May 31, 2026 | $3.64M | -21.3% |
| Q2 FY2026CQ1 2026 | Feb 28, 2026 | $5.24M | -19.9% |
| Q1 FY2026CQ4 2025 | Nov 30, 2025 | $4.44M | -45.3% |
| Q4 FY2025CQ3 2025 | Aug 31, 2025 | $1.95M | -70.3% |
| Q3 FY2025CQ2 2025 | May 31, 2025 | $4.63M | -45.6% |
| Q2 FY2025CQ1 2025 | Feb 28, 2025 | $6.54M | +36.5% |
| Q1 FY2025CQ4 2024 | Nov 30, 2024 | $8.12M | +300.6% |
| Q4 FY2024CQ3 2024 | Aug 31, 2024 | $6.56M | +343.6% |
| Q3 FY2024CQ2 2024 | May 31, 2024 | $8.51M | +147.7% |
| Q2 FY2024CQ1 2024 | Feb 29, 2024 | $4.79M | +35.4% |
| Q1 FY2024CQ4 2023 | Nov 30, 2023 | $2.03M | -57.8% |
| Q4 FY2023CQ3 2023 | Aug 31, 2023 | $1.48M | -76.0% |
| Q3 FY2023CQ2 2023 | May 31, 2023 | $3.43M | -53.2% |
| Q2 FY2023CQ1 2023 | Feb 28, 2023 | $3.54M | -60.3% |
| Q1 FY2023CQ4 2022 | Nov 30, 2022 | $4.80M | -52.8% |
| Q4 FY2022CQ3 2022 | Aug 31, 2022 | $6.16M | -47.6% |
| Q3 FY2022CQ2 2022 | May 31, 2022 | $7.34M | -13.8% |
| Q2 FY2022CQ1 2022 | Feb 28, 2022 | $8.91M | -9.2% |
| Q1 FY2022CQ4 2021 | Nov 30, 2021 | $10.18M | +1688.1% |
| Q4 FY2021CQ3 2021 | Aug 31, 2021 | $11.75M | +795.0% |
| Q3 FY2021CQ2 2021 | May 31, 2021 | $8.51M | +314.6% |
| Q2 FY2021CQ1 2021 | Feb 28, 2021 | $9.82M | +1185.7% |
| Q1 FY2021CQ4 2020 | Nov 30, 2020 | $569.07K | -58.0% |
| Q4 FY2020CQ3 2020 | Aug 31, 2020 | $1.31M | -2.7% |
| Q3 FY2020CQ2 2020 | May 31, 2020 | $2.05M | -0.9% |
| Q2 FY2020CQ1 2020 | Feb 29, 2020 | $763.61K | -63.1% |
| Q1 FY2020CQ4 2019 | Nov 30, 2019 | $1.36M | -50.1% |
| Q4 FY2019CQ3 2019 | Aug 31, 2019 | $1.35M | -22.3% |
| Q3 FY2019CQ2 2019 | May 31, 2019 | $2.07M | -0.5% |
| Q2 FY2019CQ1 2019 | Feb 28, 2019 | $2.07M | -10.8% |
| Q1 FY2019CQ4 2018 | Nov 30, 2018 | $2.72M | +22.9% |
| Q4 FY2018CQ3 2018 | Aug 31, 2018 | $1.74M | -31.4% |
| Q3 FY2018CQ2 2018 | May 31, 2018 | $2.08M | -25.4% |
| Q2 FY2018CQ1 2018 | Feb 28, 2018 | $2.32M | +342.6% |
| Q1 FY2018CQ4 2017 | Nov 30, 2017 | $2.21M | +1678.5% |
| Q4 FY2017CQ3 2017 | Aug 31, 2017 | $2.53M | +2612.1% |
| Q3 FY2017CQ2 2017 | May 31, 2017 | $2.79M | – |
| Q2 FY2017CQ1 2017 | Feb 28, 2017 | $523.63K | – |
| Q1 FY2017CQ4 2016 | Nov 30, 2016 | $124.25K | – |
| Q4 FY2016CQ3 2016 | Aug 31, 2016 | $93.41K | – |
See a number that looks wrong?